The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: a pathophysiological update

MA Nauck, DR Quast, J Wefers… - Diabetes, Obesity and …, 2021 - Wiley Online Library
The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐
like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion …

Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

S Hædersdal, A Andersen, FK Knop… - Nature Reviews …, 2023 - nature.com
Insulin and glucagon exert opposing effects on glucose metabolism and, consequently,
pancreatic islet β-cells and α-cells are considered functional antagonists. The intra-islet …

Incretin hormones: Their role in health and disease

MA Nauck, JJ Meier - Diabetes, Obesity and Metabolism, 2018 - Wiley Online Library
Incretin hormones are gut peptides that are secreted after nutrient intake and stimulate
insulin secretion together with hyperglycaemia. GIP (glucose‐dependent insulinotropic …

The cells of the islets of Langerhans

G Da Silva Xavier - Journal of clinical medicine, 2018 - mdpi.com
Islets of Langerhans are islands of endocrine cells scattered throughout the pancreas. A
number of new studies have pointed to the potential for conversion of non-β islet cells in to …

[HTML][HTML] The incretin system in healthy humans: the role of GIP and GLP-1

JJ Holst - Metabolism, 2019 - Elsevier
The incretin effect, the amplification of insulin secretion occurring when glucose is taken in
orally as compared to infused intravenously, is one of the factors that help the body to …

Peptidomics: A review of clinical applications and methodologies

RE Foreman, AL George, F Reimann… - Journal of Proteome …, 2021 - ACS Publications
Improvements in both liquid chromatography (LC) and mass spectrometry (MS)
instrumentation have greatly enhanced proteomic and small molecule metabolomic analysis …

Glucagon and amino acids are linked in a mutual feedback cycle: the liver–α-cell axis

JJ Holst, NJ Wewer Albrechtsen, J Pedersen… - Diabetes, 2017 - diabetesjournals.org
Glucagon is usually viewed as an important counterregulatory hormone in glucose
metabolism, with actions opposing those of insulin. Evidence exists that shows glucagon is …

Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation

K Færch, D Vistisen, G Pacini, SS Torekov… - Diabetes, 2016 - diabetesjournals.org
Hyperinsulinemia is an adaptive mechanism that enables the maintenance of
normoglycemia in the presence of insulin resistance. We assessed whether glucagon is also …

[HTML][HTML] The role of glucagon in the pathophysiology and treatment of type 2 diabetes

S Hædersdal, A Lund, FK Knop, T Vilsbøll - Mayo Clinic Proceedings, 2018 - Elsevier
Type 2 diabetes is a disease involving both inadequate insulin levels and increased
glucagon levels. While glucagon and insulin work together to achieve optimal plasma …

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

T Jorsal, NA Rhee, J Pedersen, CD Wahlgren… - Diabetologia, 2018 - Springer
Aims/hypothesis Enteroendocrine K and L cells are pivotal in regulating appetite and
glucose homeostasis. Knowledge of their distribution in humans is sparse and it is unknown …